These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 24335564)

  • 21. Chronic kidney disease and bone metabolism.
    Kazama JJ; Matsuo K; Iwasaki Y; Fukagawa M
    J Bone Miner Metab; 2015 May; 33(3):245-52. PubMed ID: 25653092
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Chronic kidney disease--mineral and bone disorder: why and how to control phosphate].
    Pavlović D; Katicić D; Josipović J
    Acta Med Croatica; 2012 Oct; 66 Suppl 2():64-7. PubMed ID: 23513419
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [CIP and CAP fragments of parathormone and selected parameters of calcium-phosphate balance in patients with chronic kidney disease treated with repeated haemodialysis].
    Polak-Jonkisz D; Zwolińska D; Nahaczewska W
    Pediatr Endocrinol Diabetes Metab; 2010; 16(1):25-8. PubMed ID: 20529602
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Management of chronic kidney disease mineral-bone disorder.
    Fadem SZ; Moe SM
    Adv Chronic Kidney Dis; 2007 Jan; 14(1):44-53. PubMed ID: 17200043
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Brazilian guidelines for bone and mineral disorders in CKD children].
    Lima EM; Gesteira Mde F; Bandeira Mde F;
    J Bras Nefrol; 2011 Apr; 33 Suppl 1():42-57. PubMed ID: 21655859
    [No Abstract]   [Full Text] [Related]  

  • 26. C-reactive Protein: Repeated Measurements will Improve Dialysis Patient Care.
    Cobo G; Qureshi AR; Lindholm B; Stenvinkel P
    Semin Dial; 2016; 29(1):7-14. PubMed ID: 26360923
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predicting progression to chronic kidney disease after recovery from acute kidney injury.
    Heung M; Chawla LS
    Curr Opin Nephrol Hypertens; 2012 Nov; 21(6):628-34. PubMed ID: 23010757
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Renal function trajectory is more important than chronic kidney disease stage for managing patients with chronic kidney disease.
    Rosansky SJ
    Am J Nephrol; 2012; 36(1):1-10. PubMed ID: 22699366
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Therapy for the altered mineral metabolism of chronic kidney disease: implications for vascular calcification.
    Saab G; Whaley-Connell AT; Khanna R; Sowers JR
    Ther Adv Cardiovasc Dis; 2007 Dec; 1(2):107-12. PubMed ID: 19124399
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bone mineral density in patients with predialysis chronic kidney disease.
    Aggarwal HK; Jain D; Yadav S; Kaverappa V
    Ren Fail; 2013 Sep; 35(8):1105-11. PubMed ID: 23879438
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bisphosphonates in chronic kidney disease; balancing potential benefits and adverse effects on bone and soft tissue.
    Toussaint ND; Elder GJ; Kerr PG
    Clin J Am Soc Nephrol; 2009 Jan; 4(1):221-33. PubMed ID: 18987295
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vascular calcification.
    Massy ZA; Drüeke TB
    Curr Opin Nephrol Hypertens; 2013 Jul; 22(4):405-12. PubMed ID: 23722182
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metabolomics in chronic kidney disease.
    Zhao YY
    Clin Chim Acta; 2013 Jun; 422():59-69. PubMed ID: 23570820
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effectiveness of multidisciplinary care for chronic kidney disease in Taiwan: a 3-year prospective cohort study.
    Chen YR; Yang Y; Wang SC; Chiu PF; Chou WY; Lin CY; Chang JM; Chen TW; Ferng SH; Lin CL
    Nephrol Dial Transplant; 2013 Mar; 28(3):671-82. PubMed ID: 23223224
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Chronic kidney disease: therapy and care].
    Noel N; Gaha K; Rieu P
    Rev Prat; 2012 Jan; 62(1):43-51. PubMed ID: 22335066
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Consequences of chronic kidney disease--mineral and bone disorder: a progressive disease.
    Smith KR; Smelt SC
    Nephrol Nurs J; 2009; 36(1):49-55. PubMed ID: 19271624
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Emerging biomarkers of chronic kidney disease in children.
    Greenberg JH; Kakajiwala A; Parikh CR; Furth S
    Pediatr Nephrol; 2018 Jun; 33(6):925-933. PubMed ID: 28624980
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Advances in the Detection, Mechanism and Therapy of Chronic Kidney Disease.
    Dong Y; Qu X; Wu G; Luo X; Tang B; Wu F; Fan L; Dev S; Liang T
    Curr Pharm Des; 2019; 25(40):4235-4250. PubMed ID: 31742493
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metabolic biomarkers for chronic kidney disease.
    Breit M; Weinberger KM
    Arch Biochem Biophys; 2016 Jan; 589():62-80. PubMed ID: 26235490
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bone, inflammation and chronic kidney disease.
    Mazzaferro S; De Martini N; Rotondi S; Tartaglione L; Ureña-Torres P; Bover J; Pasquali M;
    Clin Chim Acta; 2020 Jul; 506():236-240. PubMed ID: 32275989
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.